[Explanatory Note Company Common Stock Exchange Act This Registration Statement on Form 8-A is being filed by China Pharma Holdings, Inc., a Delaware corporation (the “ Item 1. Description of the Company’s Securities to be Registered Commission 1]
[Explanatory Note Company Common Stock Exchange Act This Registration Statement on Form 8-A is being filed by China Pharma Holdings, Inc., a Delaware corporation (the “ Item 1. Description of the Company’s Securities to be Registered Commission 1]
[FORM 8-K CURRENT REPORT August 28, 2009 China Pharma Holdings, Inc ------------------------------ Delaware (State or other jurisdiction of incorporation) 000-29532 73-1564807 (IRS Employer Identification Number)]
[Sinovac Obtains Initial Order of H1N1 Vaccine from Chinese Central Government BEIJING, Sept. 4 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NYSE: SVA), a leading provider of biopharmaceutical products in China, announced today that the Ministry of Industry and Information Technology of the People's Republic of China has issued the initial order to Sinovac to purchase H1N1 vaccine for the national stockpiling] [FORM 6-K __________ __________ SINOVAC BIOTECH LTD. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China X Form 20-F X Yes _______ No N/A 82- SINOVAC BIOTECH LTD. Form 6-K TABLE OF CONTENTS Page 3 4]
[Sinovac Obtains Initial Order of H1N1 Vaccine from Chinese Central Government BEIJING, Sept. 4 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NYSE: SVA), a leading provider of biopharmaceutical products in China, announced today that the Ministry of Industry and Information Technology of the People's Republic of China has issued the initial order to Sinovac to purchase H1N1 vaccine for the national stockpiling] [FORM 6-K __________ __________ SINOVAC BIOTECH LTD. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China X Form 20-F X Yes _______ No N/A 82- SINOVAC BIOTECH LTD. Form 6-K TABLE OF CONTENTS Page 3 4]
[] [RECON TECHNOLOGY, LTD CODE OF BUSINESS CONDUCT AND ETHICS This Code of Business Conduct and Ethics covers a wide range of business practices and procedures. It does not cover every issue that may arise, but it sets out basic principles to guide the employees of Recon Technology, Ltd and its subsidiaries (the Company). All of our employees must conduct themselves] [CERTIFICATION I, Yin Shenping , certify that: (1) I have reviewed this Annual Report on Form 10-K of Recon Technology, Ltd; (2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION I, Jia Liu, certify that: (1) I have reviewed this Annual Report on Form 10-K of Recon Technology, Ltd; (2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 2. The information contained in the Report fairly presents, in all material respects, the consolidated financial condition and results of operations of the Company. September 28, 2009 Yin Shenping Chief Executive Officer EX-32.1 5 dex321.htm SECTION 906 CEO CERTIFICATION] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 2. The information contained in the Report fairly presents, in all material respects, the consolidated financial condition and results of operations of the Company. September 28, 2009 Jia Liu Chief Financial Officer EX-32.2 6 dex322.htm SECTION 906 CFO CERTIFICATION] [RECON TECHNOLOGY, LTD CHARTER OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS 1. Purpose The Audit Committee of Recon Technology, Ltd (the Company) is appointed by the Board of Directors to assist the Board in fulfilling its oversight responsibilities by monitoring and reviewing: The integrity of the Companys financial reports and other financial information provided by the Company]
[Sinovac Obtains Production License for H1N1 Vaccine BEIJING, Sept. 3 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NYSE: SVA), a leading provider of biopharmaceutical products in China, announced today that the State Food and Drug Administration (SFDA) has approved the registration application for PANFLU.1, Sinovac's H1N1 vaccine, and has issued Sinovac a production license for this vaccine. Following top-line results which showed] [FORM 6-K __________ __________ SINOVAC BIOTECH LTD. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China X Form 20-F X Yes _______ No N/A 82- SINOVAC BIOTECH LTD. Form 6-K TABLE OF CONTENTS Page 3 4]
[] [RECON TECHNOLOGY, LTD CODE OF BUSINESS CONDUCT AND ETHICS This Code of Business Conduct and Ethics covers a wide range of business practices and procedures. It does not cover every issue that may arise, but it sets out basic principles to guide the employees of Recon Technology, Ltd and its subsidiaries (the Company). All of our employees must conduct themselves] [CERTIFICATION I, Yin Shenping , certify that: (1) I have reviewed this Annual Report on Form 10-K of Recon Technology, Ltd; (2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION I, Jia Liu, certify that: (1) I have reviewed this Annual Report on Form 10-K of Recon Technology, Ltd; (2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 2. The information contained in the Report fairly presents, in all material respects, the consolidated financial condition and results of operations of the Company. September 28, 2009 Yin Shenping Chief Executive Officer EX-32.1 5 dex321.htm SECTION 906 CEO CERTIFICATION] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 2. The information contained in the Report fairly presents, in all material respects, the consolidated financial condition and results of operations of the Company. September 28, 2009 Jia Liu Chief Financial Officer EX-32.2 6 dex322.htm SECTION 906 CFO CERTIFICATION] [RECON TECHNOLOGY, LTD CHARTER OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS 1. Purpose The Audit Committee of Recon Technology, Ltd (the Company) is appointed by the Board of Directors to assist the Board in fulfilling its oversight responsibilities by monitoring and reviewing: The integrity of the Companys financial reports and other financial information provided by the Company]
[Sinovac Obtains Production License for H1N1 Vaccine BEIJING, Sept. 3 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NYSE: SVA), a leading provider of biopharmaceutical products in China, announced today that the State Food and Drug Administration (SFDA) has approved the registration application for PANFLU.1, Sinovac's H1N1 vaccine, and has issued Sinovac a production license for this vaccine. Following top-line results which showed] [FORM 6-K __________ __________ SINOVAC BIOTECH LTD. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China X Form 20-F X Yes _______ No N/A 82- SINOVAC BIOTECH LTD. Form 6-K TABLE OF CONTENTS Page 3 4]
